J&J Worldwide Pharama Sales Growth YoY

Loading...
Loading...
  • Remicade Sales Grew From $1,689M To $1,782M, 7.1%
  • Xarelto Sales Grew From $246M To $414M, 68.3%
  • Stelara Sales Grew From $543M To $370M, 46.8%
  • Olysio/Sovriad $796M
  • Velcade Sales Fells From $404M To $389M, Decline Of 3.7%
  • Prezista Sales Grew From $410M To $446M, 8.8%
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...